A/S ORTHANA KEMISK FABRIK
CVR 15248912 · Public limited company (A/S) · Active · Low risk
A/S ORTHANA KEMISK FABRIK is a Public limited company (A/S), founded on , based in Kastrup. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK 28.7m and a net result of DKK -7.7m. CEO: Helle Rørvig.
Bankruptcy risk for A/S ORTHANA KEMISK FABRIK
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 15248912
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (92 years)
- Address
- Englandsvej 350
2770 Kastrup - Municipality
- Tårnby
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 1.0m
- Employees
- 27 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 30 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 34.5% |
| Current ratio | 123% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 20.9m | DKK 12.1m |
| Net profit | DKK -7.7m | DKK -11.3m |
| Equity | DKK 28.7m | DKK -3.5m |
| Total assets | DKK 83.3m | DKK 58.8m |
| Cash | DKK 61k | – |
| Short-term debt | DKK 45.8m | – |
| Avg. employees | 37 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 164 | ||
| 1 Jul 2023 – 30 Jun 2024 | 165 | ||
| 1 Jul 2022 – 30 Jun 2023 | 174 | ||
| 1 Jul 2021 – 30 Jun 2022 | 158 | ||
| 1 Jul 2020 – 30 Jun 2021 | 162 | ||
| 1 Jul 2019 – 30 Jun 2020 | 129 | ||
| 1 Jul 2018 – 30 Jun 2019 | 155 | ||
| 1 Jul 2017 – 30 Jun 2018 | 171 | ||
| 1 Jul 2016 – 30 Jun 2017 | 174 | ||
| 1 Jul 2015 – 30 Jun 2016 | 161 | ||
| 1 Jul 2014 – 30 Jun 2015 | 163 | ||
| 1 Jul 2013 – 30 Jun 2014 | 171 | ||
| 1 Jul 2012 – 30 Jun 2013 | 165 | ||
| 1 Jul 2011 – 30 Jun 2012 | 157 | ||
| 1 Jul 2010 – 30 Jun 2011 | 152 | ||
| 1 Jul 2009 – 30 Jun 2010 | 146 | ||
| 1 Jul 2008 – 30 Jun 2009 | 120 | ||
| 1 Jul 2007 – 30 Jun 2008 | 146 | ||
| 1 Jul 2006 – 30 Jun 2007 | 155 | ||
| 1 Jul 2005 – 30 Jun 2006 | 142 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Helle Rørvig | Current | |
| CEO | Erik Vilhelm Balslev | ||
| CEO | Peter Rørvig | ||
| Board | Peter Rørvig | Current | |
| Board | Niels Ulrik Heine | Current | |
| Board | Helle Rørvig | Current | |
| Board | Erik Vilhelm Balslev | ||
| Board | Niels Otto Thiesen | ||
| Board | Svend Blankholm | ||
| Owner (100%) | H&P Rørvig Holding A/S | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB |
The CEOs' other companies
Helle Rørvig – 5 other companies
- BIOFAC A/S Active
- DANIPHARM A/S Active
- H&P Rørvig Holding A/S Active
- PHARMADAN A/S Active
- ZPD A/S Active
Erik Vilhelm Balslev – 3 other companies
- BIOFAC A/S Active
- DANIPHARM A/S Active
- PHARMADAN ApS Fusioneret
Peter Rørvig – 9 other companies
- BIOFAC A/S Active
- BIOFAC HOLDING A/S Fusioneret
- DANIPHARM A/S Active
- H&P Rørvig Holding A/S Active
- N. THIESEN HOLDING A/S Active
- PHARMADAN A/S Active
- PHARMADAN ApS Fusioneret
- R & S PHARMADAN ApS Fusioneret
- ZPD A/S Active
Address history (1 moves)
| Englandsvej 350, 2770 Kastrup | |
| Englandsvej 350, 2770 Kastrup |
Employees per year
Other companies at the same address
- BIOFAC A/S Active
- BIOFAC HOLDING A/S Fusioneret
- DANIPHARM A/S Active
- PHARMADAN A/S Active
- PHARMADAN ApS Fusioneret
Similar companies in Tårnby
- BIOFAC A/S Kastrup
- DANIPHARM A/S Kastrup
Questions and answers about A/S ORTHANA KEMISK FABRIK
Has A/S ORTHANA KEMISK FABRIK gone bankrupt?
No, A/S ORTHANA KEMISK FABRIK is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of A/S ORTHANA KEMISK FABRIK?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of A/S ORTHANA KEMISK FABRIK?
Helle Rørvig is the CEO of A/S ORTHANA KEMISK FABRIK.
Who is the auditor of A/S ORTHANA KEMISK FABRIK?
A/S ORTHANA KEMISK FABRIK most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was A/S ORTHANA KEMISK FABRIK founded?
A/S ORTHANA KEMISK FABRIK was founded on 7 March 1934.
What is the equity of A/S ORTHANA KEMISK FABRIK?
Equity was DKK 28.7m according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.